These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7829260)

  • 1. Analysis of the NF2 tumor-suppressor gene and of chromosome 22 deletions in gliomas.
    Hoang-Xuan K; Merel P; Vega F; Hugot JP; Cornu P; Delattre JY; Poisson M; Thomas G; Delattre O
    Int J Cancer; 1995 Feb; 60(4):478-81. PubMed ID: 7829260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of heterozygosity on chromosome 22 in human gliomas does not inactivate the neurofibromatosis type 2 gene.
    Watkins D; Ruttledge MH; Sarrazin J; Rangaratnam S; Poisson M; Delattre JY; Rouleau GA
    Cancer Genet Cytogenet; 1996 Nov; 92(1):73-8. PubMed ID: 8956876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors.
    Ng HK; Lau KM; Tse JY; Lo KW; Wong JH; Poon WS; Huang DP
    Neurosurgery; 1995 Oct; 37(4):764-73. PubMed ID: 8559307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for mutations in the neurofibromatosis type 2 (NF2) gene in sporadic meningiomas.
    De Vitis LR; Tedde A; Vitelli F; Ammannati F; Mennonna P; Bigozzi U; Montali E; Papi L
    Hum Genet; 1996 May; 97(5):632-7. PubMed ID: 8655144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neurofibromatosis type 2 gene is inactivated in schwannomas.
    Twist EC; Ruttledge MH; Rousseau M; Sanson M; Papi L; Merel P; Delattre O; Thomas G; Rouleau GA
    Hum Mol Genet; 1994 Jan; 3(1):147-51. PubMed ID: 8162016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatic mutations in the neurofibromatosis type 2 gene in sporadic meningiomas.
    Papi L; De Vitis LR; Vitelli F; Ammannati F; Mennonna P; Montali E; Bigozzi U
    Hum Genet; 1995 Mar; 95(3):347-51. PubMed ID: 7868131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitive detection of deletions of one or more exons in the neurofibromatosis type 2 (NF2) gene by multiplexed gene dosage polymerase chain reaction.
    Diebold R; Bartelt-Kirbach B; Evans DG; Kaufmann D; Hanemann CO
    J Mol Diagn; 2005 Feb; 7(1):97-104. PubMed ID: 15681480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletions on chromosome 22 in sporadic meningioma.
    Ruttledge MH; Xie YG; Han FY; Peyrard M; Collins VP; Nordenskjöld M; Dumanski JP
    Genes Chromosomes Cancer; 1994 Jun; 10(2):122-30. PubMed ID: 7520265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosome 19q deletions in human gliomas overlap telomeric to D19S219 and may target a 425 kb region centromeric to D19S112.
    Yong WH; Chou D; Ueki K; Harsh GR; von Deimling A; Gusella JF; Mohrenweiser HW; Louis DN
    J Neuropathol Exp Neurol; 1995 Sep; 54(5):622-6. PubMed ID: 7666049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A region of common deletion in 22q13.3 in human glioma associated with astrocytoma progression.
    Oskam NT; Bijleveld EH; Hulsebos TJ
    Int J Cancer; 2000 Feb; 85(3):336-9. PubMed ID: 10652423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-resolution profiling of an 11 Mb segment of human chromosome 22 in sporadic schwannoma using array-CGH.
    Mantripragada KK; Buckley PG; Benetkiewicz M; De Bustos C; Hirvelä C; Jarbo C; Bruder CE; Wensman H; Mathiesen T; Nyberg G; Papi L; Collins VP; Ichimura K; Evans G; Dumanski JP
    Int J Oncol; 2003 Mar; 22(3):615-22. PubMed ID: 12579316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the neurofibromatosis 2 gene in human ependymomas and astrocytomas.
    Rubio MP; Correa KM; Ramesh V; MacCollin MM; Jacoby LB; von Deimling A; Gusella JF; Louis DN
    Cancer Res; 1994 Jan; 54(1):45-7. PubMed ID: 8261460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular genetic alterations on chromosomes 11 and 22 in ependymomas.
    Lamszus K; Lachenmayer L; Heinemann U; Kluwe L; Finckh U; Höppner W; Stavrou D; Fillbrandt R; Westphal M
    Int J Cancer; 2001 Mar; 91(6):803-8. PubMed ID: 11275983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of heterozygosity on chromosome 10, 13q(Rb), 17p, and p53 gene mutations in human brain gliomas.
    Lee SH; Kim JH; Rhee CH; Kang YS; Lee JH; Hong SI; Choi KS
    J Korean Med Sci; 1995 Dec; 10(6):442-8. PubMed ID: 8924230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A group of schwannomas with interstitial deletions on 22q located outside the NF2 locus shows no detectable mutations in the NF2 gene.
    Bruder CE; Ichimura K; Tingby O; Hirakawa K; Komatsuzaki A; Tamura A; Yuasa Y; Collins VP; Dumanski JP
    Hum Genet; 1999 May; 104(5):418-24. PubMed ID: 10394935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas.
    Bianchi AB; Mitsunaga SI; Cheng JQ; Klein WM; Jhanwar SC; Seizinger B; Kley N; Klein-Szanto AJ; Testa JR
    Proc Natl Acad Sci U S A; 1995 Nov; 92(24):10854-8. PubMed ID: 7479897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetic investigation of the neurofibromatosis type 2 tumor suppressor gene in sporadic meningioma.
    Harada T; Irving RM; Xuereb JH; Barton DE; Hardy DG; Moffat DA; Maher ER
    J Neurosurg; 1996 May; 84(5):847-51. PubMed ID: 8622160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity on chromosome 22 in ovarian carcinoma is distal to and is not accompanied by mutations in NF2 at 22q12.
    Englefield P; Foulkes WD; Campbell IG
    Br J Cancer; 1994 Nov; 70(5):905-7. PubMed ID: 7947096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tight association of loss of merlin expression with loss of heterozygosity at chromosome 22q in sporadic meningiomas.
    Ueki K; Wen-Bin C; Narita Y; Asai A; Kirino T
    Cancer Res; 1999 Dec; 59(23):5995-8. PubMed ID: 10606247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.